page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
page 80
page 81
page 82
page 83
page 84

rolling that out across the United States,” he says, “and we’ll complete that implementation later this year; there are other tests on the horizon that we continue to research and to pilot to gauge the public’s interest.” But new tests have to be carefully thought out and planned, to ensure they are medically necessary, suitable for a mass market and can be carried out to the high standards required. There also has to be a treatment option for the consumer. “You don’t want to tell somebody they are at risk for a life threatening disease if there’s nothing you can do about it,” says Campbell. “We’re not going to go out and screen for terminal cancer.” much higher rate of false positives with mammograms.” It’s a good thing that Life Line Screening is affordable, because these screenings are typically not yet covered by insurance. Greenberg points out that the incidence of positive findings in mammograms is about one percent, some of which will be false positives, but of the five million people so far tested by Life Line Screening, people with no symptoms, about eight percent have been found to have significant vascular disease. “And yet mammograms are routinely covered by insurance companies and by Medicare, and vascular screenings are not. And cardiovascular disease kills 20 times more people than breast cancer. People don’t get it yet.” Life Line Screening has grown phenomenally since its inception in 1993, and intends to continue doing so, with a multi-faceted growth strategy. “We are making plans to take the business overseas,” says Campbell. “We hope to be in another country this year with plans to go into other markets in ensuing years. Vascular disease is not a condition unique to Americans in the United States.” New tests are another opportunity. Life Line Screening introduced finger stick blood tests last spring, for glucose, lipids and C-reactive protein, a marker for heart disease. “We’re Customer focus May 07 Businessexcellence 23 We are serious about your success. Servicing the Database Management Industry for Nearly 15 Years • Full-Service Database Management • Merge/Purge Processing • 24-Hour Thanks You Receipting • NCOA & Deceased File Processing • Customized Reporting • Comprehensive File Audits • Web-Based Online Access “Where information and integrity merge.” Call Dave Laughlin for more information 800.248.9834

Businessexcellence May 07 24 Tools that have proven themselves in manufacturing can be harnessed to improve the operation of IT departments. Mike Bawn and Jeff Watzka explain how LeanSigma can create excellence through a new approach to IT management Information technology organizations are stretched thin these days. Whether they are stand-alone outsource providers or organizationally embedded departments, all IT organizations are being tasked to do more with less, improve quality and increase operating margins. Traditionally, the approach to solving these issues has been adding resources—new and more powerful technology, more staff or additional controls. While this was never LeanSigma in the data center